 | Up a level |
Journal Article
Besse, Benjamin, Drilon, Alexander E., Solomon, Benjamin J., Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, Lin, Aimee K., French, Pearl Plernjit, Goto, Koichi and Gautschi, Oliver (2021). Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion plus non-small cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Bunn, Paul A., Jr., Minna, John D., Augustyn, Alexander, Gazdar, Adi F., Ouadah, Youcef, Krasnow, Mark A., Berns, Anton, Brambilla, Elisabeth, Rekhtman, Natasha, Massion, Pierre P., Niederst, Matthew, Peifer, Martin 
ORCID: 0000-0002-5243-5503, Yokota, Jun, Govindan, Ramaswamy, Poirier, John T., Byers, Lauren A., Wynes, Murry W., McFadden, David G., MacPherson, David ORCID: 0000-0003-3729-907X, Hann, Christine L., Farago, Anna F., Dive, Caroline ORCID: 0000-0002-1726-8850, Teicher, Beverly A., Peacock, Craig D., Johnson, Jane E., Cobb, Melanie H., Wendel, Hans -Guido, Spigel, David, Sage, Julien, Yang, Ping, Pietanza, M. Catherine, Krug, Lee M., Heymach, John, Ujhazy, Peter, Zhou, Caicun, Goto, Koichi, Dowlati, Afshin, Christensen, Camilla Laulund, Park, Keunchil, Einhorn, Lawrence H., Edelman, Martin J., Giaccone, Giuseppe ORCID: 0000-0002-5023-7562, Gerber, David E., Salgia, Ravi, Owonikoko, Taofeek, Malik, Shakun, Karachaliou, Niki, Gandara, David R., Slotman, Ben J., Blackhall, Fiona ORCID: 0000-0001-8716-3395, Goss, Glenwood, Thomas, Roman, Rudin, Charles M. and Hirsch, Fred R.
(2016).
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
J. Thorac. Oncol., 11 (4).
S. 453 - 475.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Drilon, Alexander E., Gautschi, Oliver, Besse, Benjamin, Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, French, Pearl Plernjit, Lin, Aimee K., Goto, Koichi and Solomon, Benjamin J. (2021). Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Solomon, Benjamin J., Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jurgen, Elamin, Yasir, Davis, Hannah M., Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K., Loong, Herbert H., Novello, Silvia, Arriola, Edurne, Perol, Maurice, Goto, Koichi and Santini, Fernando C. . Phase III study of selpercatinib vs chemotherapy plus /- pembrolizumab in untreated RET positive non-small-cell lung cancer. Future Oncol.. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301